| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 52.4892 | 55 |
| GSM780708 | Untreated after 4 days (C2_1) | 49.0231 | 45 |
| GSM780709 | Untreated after 4 days (C3_1) | 46.4637 | 34 |
| GSM780719 | Untreated after 4 days (C1_2) | 53.1452 | 56 |
| GSM780720 | Untreated after 4 days (C2_2) | 49.3667 | 46 |
| GSM780721 | Untreated after 4 days (C3_2) | 42.7475 | 16 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 44.9691 | 27 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 46.866 | 36 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 47.011 | 37 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 47.7466 | 40 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 47.7693 | 40 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 47.743 | 40 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 42.9869 | 17 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 50.9832 | 51 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 43.4401 | 19 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 49.3088 | 46 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 49.0723 | 45 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 53.2799 | 57 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 49.0851 | 45 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 52.9617 | 56 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 46.1426 | 33 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 52.7663 | 56 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 48.6613 | 44 |